Wall Street lost ground on Tuesday, with halted COVID-19 vaccine trials and an elusive U.S. stimulus agreement weighing on sentiment as third quarter earnings season got underway.
Fred Katayama reports.
Stocks Rise on Positive Vaccine Developments: What Wall Street's Saying
The Street
Stocks rose Friday, but it was a slightly different story for the week.
